Health and Healthcare

Latest Articles

All Latest Articles

149422 Articles

Douglas A. McIntyre | Jan 22, 2007 at 5:15 AM EST

Asia Markets 1/22/2007 China Mobile Up, Yahoo Japan Down

Stocks: (CAJ)(FUJ)(HIT)(HMC)(NIPNY)(NTT)(DCM)(SNE)(TM)(CHL)(CHU)(CN)(PCW)(HBC) Markets in Asia were higher The Nikkei rose .7% to 17,424. Bridgestone rose 1.9% to 2665. Canon rose…

Douglas A. McIntyre | Jan 22, 2007 at 4:59 AM EST

Sears Isn’t Ignoring the Retail Operations After All

From The Peridot Capitalist Critics of the Sears and Kmart turnarounds have long argued that if Sears Holdings (SHLD) Chairman…

Douglas A. McIntyre | Jan 22, 2007 at 4:57 AM EST

Goldman and Its Commodity Indices: Conspiracy or Just Good Indexing?

From Ticker Sense Since oil’s initial decline last Summer, conspiracy theorists have been questioning the motives behind Goldman Sachs’ move…

Douglas A. McIntyre | Jan 22, 2007 at 4:54 AM EST

TXN: What is TI Smoking To See 20 pct Handset Unit Growth? (TXN)

By William Trent, CFA of Stock Market Beat TI sees 2007 global cellphone unit sales up 20 pct | Technology…

Douglas A. McIntyre | Jan 22, 2007 at 4:52 AM EST

The Monday Edition- Economic Outlook From Bonds – Fed Focus – Earnings – Bank of Japan

By Yaser Anwar, CSC of Equity Investment Ideas In this week’s institutional newsletter I’d like to talk about: 1) Deciphering…

Douglas A. McIntyre | Jan 22, 2007 at 4:50 AM EST

GE Capital: Rewriting Derivatives Accounting

From AAO Weblog It’s been a while since one of these showed up: a derivatives accounting restatement. This morning, General…

Douglas A. McIntyre | Jan 22, 2007 at 4:49 AM EST

Friday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology VANDA PHARMACEUTICAL [VNDA] +10.30% EMERGENT BIOSOLUTION [EBS] +9.20% BOSTON LIFE SCIENCES [BLSI] +8.03% LEV PHARMACEUTICALS [LEVP.OB]…

Douglas A. McIntyre | Jan 22, 2007 at 4:47 AM EST

IBD Weekly Top Ranked Medical Stocks

From BioHealth Investor The following list represents the top ten medical stocks ranked according to Earnings Per Share and Relative…

Douglas A. McIntyre | Jan 22, 2007 at 4:46 AM EST

Biotech & Medical Venture Deals Roundup

From BioHealth Investor by Adam Rubenstein NovaVision (Boca Raton, FL) a non-invasive device that may restore vision loss in stroke…

Douglas A. McIntyre | Jan 22, 2007 at 4:44 AM EST

Tiny Biotech Javelin Pharmaceuticals Looking to Crack Pain Killer Market

From BioHealth Investor by Andrew Vaino Javelin Pharmaceuticals (JAV) is a tiny biotech focused on drug delivery. Their lead compound…

Douglas A. McIntyre | Jan 22, 2007 at 4:41 AM EST

Doctor Claims Americans Paid $150M for Stem Cell Treatment Abroad

From BioHealth Investor by H.S. AyoubBioHealth Investor.com The FDA issued a warning letter to Dr.Alfred T Sapse of Stem Cell…

Douglas A. McIntyre | Jan 22, 2007 at 4:39 AM EST

Abbott or GE – who is smarter?

By Vitaliy Katsenelson, CFA I am not a buyer of Abbott Labs(ABT) at this price, as the margin of safety…

Douglas A. McIntyre | Jan 22, 2007 at 4:38 AM EST

Explanation of Enterprise Value

Posted by David Polonitza The following article provides a detailed definition of enterprise value. To determine the proper value of…

Douglas A. McIntyre | Jan 22, 2007 at 4:05 AM EST

Key Issues For This Week (Jan 22 to 26, 2007)

These are the biggest issues for the play book this week as far as US investors are concerned. There are…

Douglas A. McIntyre | Jan 22, 2007 at 2:30 AM EST

Last Week’s Cramer Recap

This is a brief review that willdirect you to Cramer’s comments this last week, although this is ashortened list. This…

1 … 9,851 9,852 9,853 9,854 9,855 … 9,962

Latest Articles

All Latest Articles

Asia Markets 1/22/2007 China Mobile Up, Yahoo Japan Down

Sears Isn’t Ignoring the Retail Operations After All

Goldman and Its Commodity Indices: Conspiracy or Just Good Indexing?

TXN: What is TI Smoking To See 20 pct Handset Unit Growth? (TXN)

The Monday Edition- Economic Outlook From Bonds – Fed Focus – Earnings – Bank of Japan

GE Capital: Rewriting Derivatives Accounting

Friday’s Top Biotech and Medical Stocks

IBD Weekly Top Ranked Medical Stocks

Biotech & Medical Venture Deals Roundup

Tiny Biotech Javelin Pharmaceuticals Looking to Crack Pain Killer Market

Doctor Claims Americans Paid $150M for Stem Cell Treatment Abroad

Abbott or GE – who is smarter?

Explanation of Enterprise Value

Key Issues For This Week (Jan 22 to 26, 2007)

Last Week’s Cramer Recap

SpaceX IPO Could Create ‘The Biggest Short Squeeze’ of All Time on Index Funds. Here’s How That Happens.

Google Data Center Deal Will Save Xcel Energy Customers Up To $1.5 Billion Over 15 Years

How Closed-End Funds at a 12% Discount Can Turn $300,000 Into $30,000 a Year

How Closed-End Funds at a 12% Discount Can Turn $300,000 Into $30,000 a Year

In 2026, RMDs Are Still Costing Retirees Six Figures, And the New One Big Beautiful Bill Did Nothing About It

SpaceX IPO Could Create ‘The Biggest Short Squeeze’ of All Time on Index Funds. Here’s How That Happens.

Google Data Center Deal Will Save Xcel Energy Customers Up To $1.5 Billion Over 15 Years

Latest Articles

All Latest Articles

Asia Markets 1/22/2007 China Mobile Up, Yahoo Japan Down

Sears Isn’t Ignoring the Retail Operations After All

Goldman and Its Commodity Indices: Conspiracy or Just Good Indexing?

TXN: What is TI Smoking To See 20 pct Handset Unit Growth? (TXN)

The Monday Edition- Economic Outlook From Bonds – Fed Focus – Earnings – Bank of Japan

GE Capital: Rewriting Derivatives Accounting

Friday’s Top Biotech and Medical Stocks

IBD Weekly Top Ranked Medical Stocks

Biotech & Medical Venture Deals Roundup

Tiny Biotech Javelin Pharmaceuticals Looking to Crack Pain Killer Market

Doctor Claims Americans Paid $150M for Stem Cell Treatment Abroad

Abbott or GE – who is smarter?

Explanation of Enterprise Value

Key Issues For This Week (Jan 22 to 26, 2007)

Last Week’s Cramer Recap

SpaceX IPO Could Create ‘The Biggest Short Squeeze’ of All Time on Index Funds. Here’s How That Happens.

Google Data Center Deal Will Save Xcel Energy Customers Up To $1.5 Billion Over 15 Years

How Closed-End Funds at a 12% Discount Can Turn $300,000 Into $30,000 a Year

Featured Reads

How Closed-End Funds at a 12% Discount Can Turn $300,000 Into $30,000 a Year

In 2026, RMDs Are Still Costing Retirees Six Figures, And the New One Big Beautiful Bill Did Nothing About It